Cognitive‐behavioural treatment for amphetamine‐type stimulants (ATS)‐use disorders
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cognitive‐behavioural Treatment for Amphetamine‐type Stimulants (ATS)‐use Disorders." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440786/all/Cognitive‐behavioural_treatment_for_amphetamine‐type_stimulants__ATS_‐use_disorders.
Cognitive‐behavioural treatment for amphetamine‐type stimulants (ATS)‐use disorders. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440786/all/Cognitive‐behavioural_treatment_for_amphetamine‐type_stimulants__ATS_‐use_disorders. Accessed January 21, 2026.
Cognitive‐behavioural treatment for amphetamine‐type stimulants (ATS)‐use disorders. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440786/all/Cognitive‐behavioural_treatment_for_amphetamine‐type_stimulants__ATS_‐use_disorders
Cognitive‐behavioural Treatment for Amphetamine‐type Stimulants (ATS)‐use Disorders [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440786/all/Cognitive‐behavioural_treatment_for_amphetamine‐type_stimulants__ATS_‐use_disorders.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cognitive‐behavioural treatment for amphetamine‐type stimulants (ATS)‐use disorders
ID - 440786
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440786/all/Cognitive‐behavioural_treatment_for_amphetamine‐type_stimulants__ATS_‐use_disorders
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -

Cochrane Abstracts

